Chimin Health Management Co Ltd

Chart & Performance

D1W1MN

P/E

—

P/S

3.60

EPS

—

Div Yield, %

0.33%

Shrs. gr., 5y

3.98%

Rev. gr., 5y

5.09%

Revenues

895m

+6.84%

Net income

-65m

CFO

140m

-31.49%

Dividend

Jun 07, 20230.02 CNY/sh

Earnings

May 29, 2025

Profile

Chimin Health Management Co., Ltd. develops, produces, and sells human drugs and medical devices in China. The company offers non-PVC soft bag double tube double valves, single valves, and single-tube double valves; plastic bottles; and other packaging forms. It also provides safety syringes, safety injection needles, sterile syringes, irrigators, dispensers, insulin syringes, infusion sets, precision filter infusion sets, and other products; In Vitro diagnosis solutions; and hemodialysis supplies, as well as medical services. The company was formerly known as Zhejiang Chimin Pharmaceutical Co.,Ltd. Chimin Health Management Co., Ltd. was founded in 1996 and is based in Huangyan, China.

URL

https://www.chimin.cn/

IPO date

Feb 17, 2015

Employees

Domiciled in

Incorporated in

Valuation

Order:

Title CNY in thousands, except ratios and share amounts	FY	FY	FY	FY	FY	FY	FY	FY	FY
Title CNY in thousands, except ratios and share amounts	2023‑12	2022‑12	2021‑12	2020‑12	2019‑12	2018‑12	2017‑12	2016‑12	2015‑12
Income
Revenues	894,509 6.84%	837,236 -23.78%
Cost of revenue	735,786	665,269
Unusual Expense (Income)
NOPBT	158,723	171,967
NOPBT Margin	17.74%	20.54%
Operating Taxes	42	16,805
Tax Rate	0.03%	9.77%
NOPAT	158,681	155,162
Net income	(65,480) -350.56%	26,134 -82.28%
Dividends	(10,745)	(30,667)
Dividend yield	0.25%	0.71%
Proceeds from repurchase of equity	(60,235)	(1)
BB yield	1.38%	0.00%
Debt
Debt current	125,133	267,402
Long-term debt	405,997	340,275
Deferred revenue	14,007	21,179
Other long-term liabilities	15,840	2,558
Net debt	163,775	(43,526)
Cash flow
Cash from operating activities	140,202	204,654
CAPEX	(149,221)
Cash from investing activities	(248,371)
Cash from financing activities	(291,840)	329,206
FCF	78,293	63,910
Balance
Cash	361,184	649,306
Long term investments	6,171	1,896
Excess cash	322,629	609,341
Stockholders' equity	1,040,583	1,095,432
Invested Capital	1,813,302	1,757,275
ROIC	8.89%	8.89%
ROCE	7.43%	7.26%
EV
Common stock shares outstanding	545,670	492,415
Price	8.01 -8.46%	8.75 -33.42%
Market cap	4,370,818 1.44%	4,308,627 -30.16%
EV	4,618,391	4,332,574
EBITDA	268,255	256,144
EV/EBITDA	17.22	16.91
Interest	23,795	27,423
Interest/NOPBT	14.99%	15.95%